Gentamicin Ophthalmic
Gentamicin ophthalmic is an antibiotic eye preparation used to treat bacterial infections of the eye, including conjunctivitis, corneal ulcers, and eyelid infections.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 21 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Gentamicin Ophthalmic: Patient Information Guide
A plain-language walkthrough of Gentamicin Ophthalmic — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Gentamicin ophthalmic is an antibiotic used to treat bacterial infections of the eye and surrounding structures. Gentamicin Sulfate Ophthalmic Solution is indicated for:
- Conjunctivitis (bacterial pink eye)
- Keratitis and keratoconjunctivitis (bacterial infections of the cornea)
- Corneal ulcers caused by susceptible bacteria
- Blepharitis and blepharoconjunctivitis (bacterial eyelid infections)
- Acute meibomianitis (infection of the eyelid oil glands)
- Dacryocystitis (bacterial infection of the tear duct)
⚙️How it works▾
Gentamicin belongs to a class of antibiotics called aminoglycosides. It works by locking onto a structure inside bacteria called the ribosome — the part responsible for building proteins the bacteria need to survive and multiply. By blocking protein synthesis, gentamicin kills the bacteria directly. It is effective against both gram-positive and gram-negative bacteria.
Some bacteria can develop resistance to gentamicin, which is one reason it's important to use the full prescribed course and only for confirmed or suspected bacterial infections.
💊How it's taken▾
Gentamicin Sulfate Ophthalmic Solution is instilled as eye drops directly into the affected eye(s). For most infections, one or two drops are used every four hours. In more serious infections, your doctor may increase this to two drops every hour.
- Use only in the eye — this solution must never be injected
- Follow your prescriber's exact instructions for how often to use it
- If you miss a dose, use it as soon as you remember — but skip it if it's almost time for the next dose
🤒Side effects — in detail▾
The most commonly reported side effects with gentamicin ophthalmic preparations are mild and related to the eye itself:
- Burning or stinging when drops are applied
- Eye redness (conjunctival hyperemia)
- Non-specific conjunctivitis
- Minor surface damage to the eye (conjunctival epithelial defects)
Less common but more serious reactions include allergic reactions, a significant drop in platelets (thrombocytopenic purpura), and hallucinations. Bacterial and fungal corneal ulcers have also been reported during treatment. If any of these occur, contact your doctor promptly.
⚠️Warnings & precautions▾
- For eye use only — never inject: Gentamicin sulfate ophthalmic solution must never be injected into or around the eye. Injecting it under the conjunctiva or into the front chamber of the eye could cause serious damage.
- Corneal ulcers during treatment: Bacterial and fungal corneal ulcers have developed in some patients using gentamicin ophthalmic preparations. Seek care immediately if eye pain suddenly worsens or vision changes.
- Allergic reactions: Stop use and get medical help if you experience swelling, rash, or difficulty breathing.
- Rare serious reactions: Thrombocytopenic purpura (unusual bruising or bleeding due to low platelet count) and hallucinations have been reported rarely.
🔀What it interacts with▾
The FDA label for gentamicin ophthalmic solution does not identify specific drug, food, or supplement interactions for the eye drop formulation.
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Do not use if you are allergic to gentamicin or any other ingredient in the product — this is a contraindication
- Tell your doctor about all eye conditions you have before starting treatment
- This solution is strictly for use in the eye and must never be injected under any circumstances
🔬Pharmacokinetics — how your body processes it▾
When gentamicin is given by injection (not the eye drop route), it is rapidly absorbed and reaches peak blood levels within 30 to 60 minutes. It is mostly cleared from the body through the kidneys — about 70% or more is recoverable in the urine within 24 hours, largely unchanged. In people with kidney disease, the drug clears more slowly and can build up in the body. There is minimal penetration of gentamicin into eye tissues when given by injection, which is why direct application to the eye as drops is used for eye infections.
📦How to store it▾
Store at or below 25°C (77°F).
📄 Written from Gentamicin Ophthalmic’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Gentamicin Ophthalmic — the kind of thing our pharmacy team would talk through with you at the counter.
What kind of eye infection does this treat — can I use it for any red or irritated eye? ▾
How do I use the eye drops correctly? ▾
My eyes sting after I put the drops in — is that normal? ▾
Are there any serious side effects I should watch out for? ▾
Can I inject this solution around my eye if drops aren't working well? ▾
What if I forget a dose? ▾
Is Gentamicin Ophthalmic available over the counter? ▾
When was Gentamicin Ophthalmic first available? ▾
Who makes Gentamicin Ophthalmic? ▾
💬 Answers drafted from Gentamicin Ophthalmic’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Gentamicin Ophthalmic comes
Gentamicin Ophthalmic is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Eye drops
How this form is used
- Gentamicin Sulfate Ophthalmic Solution treats bacterial eye infections including conjunctivitis, keratitis, corneal ulcers, blepharitis, and dacryocystitis
- Indicated for infections caused by susceptible bacteria such as Staphylococcus aureus, Pseudomonas aeruginosa, and Neisseria gonorrhoeae
- Gentamicin Sulfate Ophthalmic Solution: instill one or two drops into the affected eye(s) every four hours
- For severe infections, Gentamicin Sulfate Ophthalmic Solution may be used as two drops every hour as directed by your doctor
- For external use in the eye only — never inject this solution
Eye ointment
📊 Gentamicin Ophthalmic across the U.S. market
How Gentamicin Ophthalmic appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Gentamicin Ophthalmic is used
A general measure of how commonly Gentamicin Ophthalmic is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Gentamicin Ophthalmic is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Gentamicin Ophthalmic prescribed? Of the 1,597 medications we measure, Gentamicin Ophthalmic ranks #533 by Medicaid prescriptions — more than 67% of them.
Utilization by Gentamicin Ophthalmic product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
gentamicin 3 MG/ML Ophthalmic Solution
Summed across the 2 of 33 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 310467
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Gentamicin Ophthalmic, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 2 of 33 listed Gentamicin Ophthalmic NDCs with Medicaid activity.
🔍 Compare Gentamicin Ophthalmic products
A representative set of FDA-listed product records for Gentamicin Ophthalmic — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Eye drops | ||||
| 3 mg/mL | Ophthalmic | A-S Medication Solutions × 3 listings | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | Akorn | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | Asclemed USA, Inc. × 2 listings | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | Bausch & Lomb Incorporated × 2 listings | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | Direct Rx × 3 listings | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | Direct_Rx × 2 listings | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | Medsource Pharmaceuticals | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | NuCare Pharmaceuticals,Inc. × 6 listings | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | NuCare Pharmaceuticals, Inc. × 2 listings | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | Pacific Pharma, Inc. × 2 listings | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | Preferred Pharmaceuticals Inc. × 3 listings | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | Proficient Rx LP × 5 listings | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | Remedyrepack Inc. × 3 listings | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | RPK Pharmaceuticals, Inc. × 4 listings | ANDA | View NDC → |
| 3 mg/mL | Ophthalmic | Sandoz Inc × 2 listings | ANDA | View NDC → |
| 💊Eye ointment | ||||
| 3 mg/g | Ophthalmic | A-S Medication Solutions | ANDA | Find on DailyMed ↗ |
| 3 mg/g | Ophthalmic | Akorn | ANDA | View NDC → |
| 3 mg/g | Ophthalmic | NuCare Pharmaceuticals,Inc. | ANDA | Find on DailyMed ↗ |
| 3 mg/g | Ophthalmic | Proficient Rx LP | ANDA | View NDC → |
Showing 45 of 45 products — FDA National Drug Code Directory. See every product, package size and price: browse all 45 Gentamicin Ophthalmic NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Gentamicin Ophthalmic — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Gentamicin Ophthalmic in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Gentamicin Ophthalmic went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 1596450 7 dose forms · 18 strengths
-
Dose form (SCDF) Injectable Solution RxCUI 1870216No current FDA listingClinical drug / strength (SCD) 5 MG/MLRxCUI 10277010 MG/MLRxCUI 23920440 MG/MLRxCUI 313996100 MG/MLRxCUI 1485222 -
Dose form (SCDF) Injection RxCUI 1870244No current FDA listingClinical drug / strength (SCD) 2 ML gentamicin 10 MG/MLRxCUI 18706762 ML gentamicin 40 MG/MLRxCUI 187065050 ML gentamicin 1.2 MG/MLRxCUI 187063350 ML gentamicin 1.6 MG/MLRxCUI 31047750 ML gentamicin 2 MG/MLRxCUI 197736100 ML gentamicin 0.8 MG/MLRxCUI 310473100 ML gentamicin 1 MG/MLRxCUI 242816100 ML gentamicin 1.2 MG/MLRxCUI 1870631 -
Dose form (SCDF) Irrigation Solution RxCUI 1870319No current FDA listingClinical drug / strength (SCD) 100 MG/MLRxCUI 1090525 -
Dose form (SCDF) Ophthalmic Ointment RxCUI 1870220In current FDA listingsClinical drug / strength (SCD) 0.003 MG/MGRxCUI 310466 -
Dose form (SCDF) Ophthalmic Solution RxCUI 1870228In current FDA listings -
Dose form (SCDF) Topical Cream RxCUI 1870264No current FDA listingClinical drug / strength (SCD) 1 MG/MLRxCUI 197735 -
Dose form (SCDF) Topical Ointment RxCUI 1870479No current FDA listingClinical drug / strength (SCD) 0.001 MG/MGRxCUI 310465
Look up RxCUI 1596450 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Gentamicin Ophthalmic is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
RxNorm drug class
Gentamicin Ophthalmic belongs to the Aminoglycoside Antibacterial class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 21 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. NuCare Pharmaceuticals,Inc. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.